Home > Boards > US Listed > Medical - Drugs > Cancer Genetics Inc. (CGIX)

Well, today CGIX already declined to $0.135 in

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Value_Investor Member Profile
 
Followed By 831
Posts 78,716
Boards Moderated 15
Alias Born 07/26/07
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 10/25/2019 8:01:23 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/25/2019 6:05:24 AM
Cancer Genetics, Inc. Announces Strategic Transactions GlobeNewswire Inc. - 10/24/2019 4:15:05 PM
Cancer Genetics Announces 1-for-30 Reverse Stock Split GlobeNewswire Inc. - 10/24/2019 8:30:05 AM
Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners GlobeNewswire Inc. - 10/17/2019 6:55:05 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/21/2019 5:29:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/20/2019 8:42:24 AM
Cancer Genetics Reports Second Quarter 2019 Financial Results and Provides Strategic Business Update GlobeNewswire Inc. - 8/20/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/19/2019 5:28:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/19/2019 4:19:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/19/2019 4:16:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/19/2019 4:14:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/19/2019 4:10:03 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/14/2019 4:06:57 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/13/2019 4:06:35 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 7/25/2019 8:01:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2019 5:30:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2019 5:23:45 PM
Cancer Genetics, Inc. Announces Strategic Transactions GlobeNewswire Inc. - 7/15/2019 4:22:03 PM
Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital ... GlobeNewswire Inc. - 7/15/2019 4:10:34 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 7/12/2019 5:17:50 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/9/2019 5:16:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/26/2019 5:29:45 PM
Innovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial Officer GlobeNewswire Inc. - 6/24/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2019 4:16:07 PM
Value_Investor   Wednesday, 10/09/19 07:07:16 PM
Re: wesley_ post# 717
Post # of 767 
Well, today CGIX already declined to $0.135 in the After-Hours session! $0.185 has formed a very strong resistance! It seems CGIX will crash to Another New low $0.06 or even $0.05 in the coming days since its current Bottom $0.085 will soon be easily broken down...

Did the company already resolve most recent serious argument problems (see the link below) between the directors?

https://www.otcmarkets.com/filing/html?id=13545011&guid=iiefUeiLHwLH63h

Anyway at $0.185 CGIX has $11,175,566.64 or $11.18M Market Value v.s. it has $5.06M Huge Debts! Even at its Bottom $0.085 CGIX still has $5,134,719.7 or $5.14M Market Value which is still more than its $5.06M Huge Debts!

I would sell out CGIX ASAP if I still owned any shares now because by selling just 100K shares of CGIX at $0.185 ~ $0.145 one could correct nice amount of cash ($18,500 ~ $14,500) which can be used to buy 4.7436M ~ 2.6364M shares of its subsidiary stock (joke low $0.19M Market Value now) at today's price levels $0.0077 ~ $0.0039!




Stock-Killers-World has spot 420 stock killers from 9000-Bagger to 2.2-Bagger since 03/05/2011
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist